Spots Global Cancer Trial Database for brain diseases
Every month we try and update this database with for brain diseases cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Study of Abemaciclib and Elacestrant in Patients With Brain Metastasis Due to HR+/HER2- Breast Cancer | NCT05386108 | Breast Neoplasm... Brain Neoplasms Neoplasms by Si... Neoplasms Breast Diseases Central Nervous... Brain Diseases Central Nervous... | Elacestrant Abemaciclib | 18 Years - | Stemline Therapeutics, Inc. | |
| Long Term Survivors of High-grade Glioma and Their Caregivers | NCT02965144 | Quality of Life Brain Diseases Depression Physical Impair... | no treatment | 18 Years - | Rigshospitalet, Denmark | |
| Long Term Survivors of High-grade Glioma and Their Caregivers | NCT02965144 | Quality of Life Brain Diseases Depression Physical Impair... | no treatment | 18 Years - | Rigshospitalet, Denmark | |
| A FIH Study of PF-07284890 in Participants With BRAF V600 Mutant Solid Tumors With and Without Brain Involvement | NCT04543188 | Malignant Melan... Carcinoma, Non-... Brain Neoplasms... Brain Neoplasms Malignant Neopl... | PF-07284890 Binimetinib Midazolam | 16 Years - | Pfizer | |
| Study of Abemaciclib and Elacestrant in Patients With Brain Metastasis Due to HR+/HER2- Breast Cancer | NCT05386108 | Breast Neoplasm... Brain Neoplasms Neoplasms by Si... Neoplasms Breast Diseases Central Nervous... Brain Diseases Central Nervous... | Elacestrant Abemaciclib | 18 Years - | Stemline Therapeutics, Inc. | |
| Study To Test the Safety and Efficacy of TVI-Brain-1 As A Treatment for Recurrent Grade IV Glioma | NCT01290692 | Grade IV Glioma Grade IV Astroc... Glioblastoma Mu... | TVI-Brain-1 | 18 Years - | TVAX Biomedical | |
| Long Term Survivors of High-grade Glioma and Their Caregivers | NCT02965144 | Quality of Life Brain Diseases Depression Physical Impair... | no treatment | 18 Years - | Rigshospitalet, Denmark | |
| Analysis of Brain Tumors Using Matrix Assisted Laser Desorption/Ionization Mass Spectrometry | NCT00592709 | Brain Diseases | 2 Years - 85 Years | Vanderbilt University Medical Center | ||
| A Phase I Study of ABT-888 in Combination With Conventional Whole Brain Radiation Therapy (WBRT) in Cancer Patients With Brain Metastases | NCT00649207 | Brain Diseases Brain Neoplasms Central Nervous... Neoplasm Metast... Nervous System ... | ABT-888 Whole Brain Rad... | 18 Years - 99 Years | AbbVie | |
| SGM-101 in Colorectal Brain Metastases. | NCT04755920 | Rectal Neoplasm... Rectum Cancer Colorectal Neop... Brain Metastase... Brain Neoplasms Brain Diseases Brain Cancer Brain Tumor Intestinal Neop... Gastrointestina... Gastrointestina... Gastrointestina... Intestinal Dise... | SGM-101 | 18 Years - | Leiden University Medical Center | |
| Neurosurgical Transitional Care Programme | NCT03593330 | Surgery Brain Tumor Brain Tumor, Re... Brain Pathology Spinal Diseases Spinal Stenosis Spinal Fusion Trigeminal Neur... Hydrocephalus Fusion of Spine Aneurysm SPINAL Fracture Chiari; Net Skull Injuries Brain Cancer Brain Metastase... Brain Diseases Brain Lesion Brain Cyst Spinal Curvatur... Spinal Instabil... Spinal Cord Neo... | Transitional Ca... | - | Barts & The London NHS Trust | |
| A Pilot Study of Bevacizumab for Neoplastic Meningitis | NCT00924820 | Neoplastic Meni... | Bevacizumab | 18 Years - | M.D. Anderson Cancer Center | |
| Study to Assess the Efficacy of XPro1595 in Patients With Mild Cognitive Impairment With Biomarkers of Inflammation | NCT05321498 | Mild Cognitive ... Alzheimer Disea... Dementia Brain Diseases Central Nervous... Nervous System ... Tauopathies Neurodegenerati... Mental Disorder... | XPro1595 Placebo | 55 Years - 80 Years | Inmune Bio, Inc. | |
| The Child in Context Intervention Study | NCT04798859 | Rehabilitation Brain Injuries Brain Injury, C... Brain Diseases Family Childhood Brain... Child Behavior Parenting | Family centered... Control | 6 Years - 16 Years | Sunnaas Rehabilitation Hospital | |
| Study to Assess the Efficacy of XPro1595 in Patients With Mild Cognitive Impairment With Biomarkers of Inflammation | NCT05321498 | Mild Cognitive ... Alzheimer Disea... Dementia Brain Diseases Central Nervous... Nervous System ... Tauopathies Neurodegenerati... Mental Disorder... | XPro1595 Placebo | 55 Years - 80 Years | Inmune Bio, Inc. | |
| Dasatinib Plus Radiation Therapy/Temozolomide in Newly-Diagnosed Glioblastoma | NCT00895960 | Glioblastoma CNS Disease Brain Diseases | Dasatinib RT (Radiotherap... TMZ (Temozolomi... | 18 Years - | M.D. Anderson Cancer Center | |
| The Child in Context Intervention Study | NCT04798859 | Rehabilitation Brain Injuries Brain Injury, C... Brain Diseases Family Childhood Brain... Child Behavior Parenting | Family centered... Control | 6 Years - 16 Years | Sunnaas Rehabilitation Hospital | |
| Study to Develop Head Stabilizer for Use During Brain Radiation Therapy | NCT03629964 | Brain Diseases Brain Cancer | Wiersma Head St... AlignRT system | 18 Years - | University of Chicago | |
| Neurosurgical Transitional Care Programme | NCT03593330 | Surgery Brain Tumor Brain Tumor, Re... Brain Pathology Spinal Diseases Spinal Stenosis Spinal Fusion Trigeminal Neur... Hydrocephalus Fusion of Spine Aneurysm SPINAL Fracture Chiari; Net Skull Injuries Brain Cancer Brain Metastase... Brain Diseases Brain Lesion Brain Cyst Spinal Curvatur... Spinal Instabil... Spinal Cord Neo... | Transitional Ca... | - | Barts & The London NHS Trust | |
| Study To Test the Safety and Efficacy of TVI-Brain-1 As A Treatment for Recurrent Grade IV Glioma | NCT01290692 | Grade IV Glioma Grade IV Astroc... Glioblastoma Mu... | TVI-Brain-1 | 18 Years - | TVAX Biomedical | |
| Phase I/II Study To Test The Safety and Efficacy of TVI-Brain-1 As A Treatment For Recurrent Grade IV Glioma | NCT01081223 | Glioma High Grade Astr... Glioblastoma Mu... | Cancer vaccine ... | 18 Years - | TVAX Biomedical |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
